STOCK TITAN

DRDGOLD Ltd. (DRD) Form 4 Filings

DRD NYSE

Here are the Form 4 insider transactions from DRDGOLD Ltd. (DRD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DRD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DRD filings page.

Rhea-AI Summary

DRDGOLD's Group Fin. & Business Dev. Mgr. Mpho Mashatola had 28,920 conditional share awards vest on October 25, 2026, equal to 60% of awards granted in 2023; they were settled one-for-one in ordinary shares for no consideration. The remaining 19,281 awards were forfeited without consideration because performance conditions were not fully satisfied. On October 27, 2026, Mashatola sold 13,014 ordinary shares in a pooled sale at a reported average of $2.4413 per share, converted from ZAR; the stated average price was ZAR 40.7170 per share. No Rule 10b5-1 plan is reported for the sale.

Rhea-AI Summary

DRDGOLD Ltd (DRD) Chief Operating Officer Jacobus Schoeman had 139,575 conditional share awards vest on October 25, 2026. They represented 60% of awards granted on October 25, 2023, and were settled one-for-one in ordinary shares for no consideration. A further 93,049 awards, the remaining 40%, were forfeited without consideration after performance conditions were not fully satisfied.

On October 27, 2026, 94,575 ordinary shares were sold on Schoeman’s behalf in a pooled sale at an average reported price of $2.4413 per share, equivalent to an average sale price of ZAR 40.7170 per share. No Rule 10b5-1 plan is reported. The reported conditional awards position represents 215,259 underlying ordinary shares, scheduled to vest on October 22, 2027, subject to continued service and performance conditions.

Rhea-AI Summary

DRDGOLD Ltd (DRD) Financial Manager Lihan Laas sold 14,787 ordinary shares on October 27, 2026, at an average price of $2.4413 per share (ZAR 40.7170, converted to U.S. dollars) in a pooled sale. On October 25, 2026, 14,787 conditional share awards vested and settled one-for-one in ordinary shares for no consideration; the remaining 9,857 awards were forfeited without consideration because performance conditions were not fully satisfied. The reported position includes 27,740 conditional share awards scheduled to vest October 22, 2027, subject to continued service and performance conditions. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

At DRDGOLD Ltd., General Manager FWGR Ops. Kgabo Moloto sold 21,999 ordinary shares on October 27, 2026, in a pooled sale at a reported $2.4413 per share. The U.S. dollar price was converted from ZAR using the South African Reserve Bank exchange rate in effect that day; the stated average sale price was ZAR 40.7170 per share. The sale was not reported as made under a Rule 10b5-1 plan.

On October 25, 2026, 21,999 conditional share awards, representing 60% of those granted to Moloto on October 25, 2023, vested based on the company’s determination of how applicable performance conditions were met and settled one-for-one in ordinary shares for no consideration. The remaining 40%, or 14,665 awards, were forfeited without consideration after the company determined the applicable performance conditions were not fully satisfied. The reported conditional-award position covers 33,927 underlying ordinary shares, scheduled to vest on October 22, 2027, subject to continued service and performance conditions.

Rhea-AI Summary

DRDGOLD Ltd Head of Technical Services Kevin Kruger had 73,830 Conditional Share Awards vest on October 25, 2026, representing 60% of awards granted October 25, 2023. They were settled one-for-one in Ordinary Shares for no consideration.

On October 27, 2026, Kruger sold 73,830 Ordinary Shares in a pooled sale at an average reported price of $2.4413 per share, converted from ZAR; the average sale price was ZAR 40.7170 per share. No Rule 10b5-1 plan is reported.

The remaining 40%, or 49,219 awards, were forfeited without consideration because the company determined that the performance conditions were not fully satisfied. Separate Conditional Share Awards tied to 186,908 underlying Ordinary Shares are scheduled to vest October 22, 2027, subject to continued service and performance conditions.

Rhea-AI Summary

DRDGOLD Ltd (DRD) reported that Ryno Bornman, Financial Manager, Ergo Ops., had 18,639 Conditional Share Awards vest on October 25, 2026, representing 60% of awards granted October 25, 2023; they were settled one-for-one in ordinary shares for no consideration. The remaining 12,425 awards, or 40%, were forfeited without consideration after the company determined applicable performance conditions were not fully satisfied. On October 27, 2026, 8,388 ordinary shares were sold on Bornman’s behalf in a pooled sale. The average sale price was ZAR 40.7170 per share; the table reports $2.4413 per share after conversion from ZAR. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

At DRDGOLD Ltd., Dean Lindecke (General Manager Ergo Ops.) had 48,948 conditional share awards vest on October 25, 2026, representing 60% of awards granted on October 25, 2023. They were settled one-for-one in ordinary shares for no consideration. The remaining 32,631 awards, representing 40%, were forfeited without consideration because the company determined the performance conditions were not fully satisfied.

On October 27, 2026, 48,948 ordinary shares were sold on Lindecke’s behalf in a pooled sale at an average $2.4413 per share; the average sale price was ZAR 40.7170 per share, converted to U.S. dollars using the South African Reserve Bank rate on the transaction date. No Rule 10b5-1 plan is reported. A separate position lists 104,957 underlying ordinary shares in conditional awards scheduled to vest October 22, 2027, subject to continued service and performance conditions.

Rhea-AI Summary

DRDGOLD Ltd. officer Henry Gouws (Head of Prod., Dir. of Ergo) received 89,160 ordinary shares on October 25, 2026, when conditional awards vested and settled one-for-one for no consideration. He sold 89,160 shares on October 27 at an average reported price of $2.4413 per share in a pooled sale. The remaining 59,440 conditional awards were forfeited without consideration after the company determined applicable performance conditions were not fully satisfied. Awards representing 186,908 underlying ordinary shares are scheduled to vest October 22, 2027, subject to continued service and performance conditions.

Rhea-AI Summary

DRDGOLD Ltd (DRD) CFO and director Henriette Hooijer was named in a pooled sale of 22,687 ordinary shares on October 27, 2026, at a reported price of $2.4413 per share; the sale was denominated in ZAR, with an average sale price of ZAR 40.7170 per share. On October 25, 2026, 50,415 conditional share awards, representing 60% of awards granted October 25, 2023, vested and were settled one-for-one in ordinary shares for no consideration. The remaining 33,610 awards (40%) were forfeited without consideration after performance conditions were not fully satisfied. A separate holding entry lists 95,415 conditional share awards scheduled to vest October 22, 2027, subject to continued service and performance conditions.

Rhea-AI Summary

DRDGOLD Ltd. CEO and director Daniel Pretorius had 262,176 conditional share awards vest on October 25, 2026; they settled one-for-one in ordinary shares for no consideration. The remaining 174,783 awards were forfeited without consideration because applicable performance conditions were not fully satisfied. He sold 117,980 ordinary shares in a pooled sale on October 27, 2026, at a converted average price of US$2.4413 per share (ZAR 40.7170 per share); no Rule 10b5-1 plan is reported. He also held awards covering 404,342 ordinary shares.

Form 4
Rhea-AI Summary

DRDGOLD LTD (DRD) reports that officer Moloto Kgabo exercised 11,586 Deferred Shares on August 13, 2026, which vested under the Company’s Single Incentive Plan and were settled one-for-one into Ordinary Shares for no consideration. The same 11,586 Ordinary Shares were then sold in a pooled sale on August 31 and September 1, 2026 at an average price of $2.7545 per share, converted from ZAR 44.4764 per share. Following these transactions, Kgabo holds 62,002 Deferred Shares.

Rhea-AI Summary

DRDGOLD LTD (DRD) reports that Chief Operating Officer Jacobus Schoeman exercised equity awards and sold shares. On August 13, 2026, 19,403 Deferred Shares previously awarded under the Company’s Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration. A pooled sale on Schoeman’s behalf then disposed of 19,403 Ordinary Shares on August 31 and September 1, 2026 at an average price of $2.7545 per share, converted from South African rand. Following related activity previously reported, Schoeman holds 166,169 Deferred Shares. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

DRDGOLD LTD (DRD) reported that officer Henry Gouws, Head of Production and Director of Ergo, exercised and settled 16,826 Deferred Shares into the same number of Ordinary Shares on August 13, 2026 at no cost under the company’s Single Incentive Plan, then sold 16,826 Ordinary Shares in market transactions on August 31 and September 1, 2026 at an average price of about $2.75 per share, converted from South African rand. Following these transactions, he continues to hold 144,077 Deferred Shares. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

DRDGOLD LTD (DRD) reported that Dean Lindecke, General Manager Ergo Ops., had 20,060 deferred shares granted under the Company’s Single Incentive Plan vest on August 13, 2026 and settle one-for-one into Ordinary Shares for no consideration.

Following this vesting, 20,060 Ordinary Shares were sold on the reporting person’s behalf in a pooled sale conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share, translated from an average sale price of ZAR 44.4764 per share. After these transactions, the reporting person held 94,415 deferred shares, with no Rule 10b5-1 trading plan reported.

Rhea-AI Summary

DRDGOLD LTD (DRD) reported that Financial Manager FWGR Ops. Laas Lihan exercised and sold equity-based awards. On August 13, 2026, 9,029 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration under the Single Incentive Plan. A pooled sale then disposed of 9,029 Ordinary Shares on August 31 and September 1, 2026 at an average of $2.7545 (ZAR 44.4764) per share. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DRDGOLD LTD (DRD) reports that officer Mashatola Mpho exercised 11,721 Deferred Shares on August 13, 2026, which vested under the Company’s Single Incentive Plan and were settled one-for-one into Ordinary Shares for no consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,275 Ordinary Shares, with the remaining 6,446 Ordinary Shares retained in the reporting person’s own name. Following these events, the reporting person holds 72,900 Deferred Shares; no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DRDGOLD LTD (DRD) reports that Financial Manager Ergo Ops. Ryno Bornman exercised previously awarded deferred equity and sold part of the resulting stake. On August 13, 2026, 12,198 Deferred Shares vested and were settled into the same number of Ordinary Shares for no cash consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,490 Ordinary Shares at $2.7545 per share, with the remaining 6,708 Ordinary Shares transferred into and retained in Bornman’s own name. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DRDGOLD LTD (DRD) reports that Kevin Kruger, Head of Technical Services, had 16,801 Deferred Shares vest on August 13, 2026 and settle into an equal number of Ordinary Shares for no consideration. In a pooled sale on August 31 and September 1, 2026, 7,561 of these Ordinary Shares were sold at an average price of $2.7545 per share, with 9,240 Ordinary Shares transferred to and retained in his name. Following these transactions, Kruger holds 143,927 Deferred Shares directly. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DRDGOLD LTD (DRD) Chief Financial Officer Henriette Hooijer reported transactions in company equity awards and shares. On August 13, 2026, 18,472 Deferred Shares granted under the Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration, and Hooijer acquired 18,472 Ordinary Shares. A pooled sale then disposed of 8,313 of those Ordinary Shares on August 31 and September 1, 2026 at an average price of $2.7545 per share (converted from South African rand), with the remaining 10,159 Ordinary Shares retained in her name. Following these events, she held 110,965 Deferred Shares, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DRDGOLD LTD (DRD) insider Daniel Pretorius, the Chief Executive Officer and a director, reported transactions involving 35,537 shares linked to previously awarded Deferred Shares. On August 13, 2026, 35,537 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration, and a pooled sale of 35,537 Ordinary Shares was later conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share equivalent to ZAR 44.4764. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (DRD) reported that an officer serving as Head of Production and Director of Ergo received an equity-based compensation award. The reporting officer acquired 76,769 deferred shares of DRDGOLD Limited on August 26, 2026, representing an award under the company’s Single Incentive Plan. These deferred shares correspond to 76,769 underlying ordinary shares and are subject to forfeiture, vesting in five equal annual installments with the final installment vesting on August 12, 2031, contingent on continued service with DRDGOLD Limited or its subsidiaries. Following this grant, the officer directly holds 160,903 deferred shares.

Rhea-AI Summary

DRDGOLD LTD (symbol: DRD) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

DRDGOLD LTD (DRD) reported that its Chief Executive Officer, serving as the reporting person, received a grant of deferred shares under the company’s Single Incentive Plan. On August 26, 2026, the reporting person acquired 163,530 deferred shares, corresponding to an equal number of underlying ordinary shares, at a stated price of $0.00 per share as an award.

After this grant, the reporting person directly holds 341,218 deferred shares in total. According to the award terms, these deferred shares are subject to forfeiture and vest in five equal annual installments, with the final installment vesting on August 12, 2031, contingent on continued service with DRDGOLD LTD or its subsidiaries through each vesting date.

Rhea-AI Summary

DRDGOLD LTD (DRD) reported that its Chief Financial Officer, as reporting person, received a grant of deferred share units. On August 26, 2026, the reporting person acquired 74,019 deferred shares at a stated price of $0.00 under the company’s Single Incentive Plan, increasing her directly held deferred shares to 129,437.

The award was granted on August 12, 2026 and accepted on August 26, 2026. These deferred shares are subject to forfeiture and vest in five equal annual installments, with the final installment vesting on August 12, 2031, contingent on continued service to DRDGOLD LTD or its subsidiaries.